ribosyltransferase, muscular dystrophy, 5-phosphorylribose 1-pyrophosphate, purine nucleotides, quadriceps muscle homogenate.
substrate and 5-phosphorylribose I-pyrophosphate as a ribose 5-phosphate donor. [ 
8-14C IInosine
Introduction monophosphate formed was separated by highvoltage electrophoresis and radioactivity was measured by liquid-scintillation counting.
2. In erythrocyte haemolysates, HGPRT activity was similar in normal and dystrophic C57 BL/6J mice but was significantly higher in dystrophic than in normal 129 ReJ mice. Elevated enzyme activity was observed only in mice that were clinically severely affected.
3. In muscle homogenates, HGPRT activity was significantly higher in dystrophic than in normal animals of both 129 ReJ and C57 BL/6J mice. Enzyme activity was not related to the severity of the disease.
4. It is suggested that changes in erythrocytes are secondary to the dystrophic process and that elevated HGPRT activity in skeletal muscle may be related to abnormal energy metabolism, possibly via the pentose monophosphate shunt.
Muscular dystrophy in the mouse was first reported by Michelson, Russell & Harman (1955) and occurred as a spontaneous autosomal recessive mutation in the Bar Harbor 129 ReJ strain (denoted dy/dy). A similar progressive myopathy was reported in a second strain, WK/ReJ, by Meier & Southard (1970) and was denoted dyZJ/dyZJ. The affected mice are similar to the allelic dy/dy mutants. For commercial retail the mutant gene was transferred to C57 BL/6J mice.
Although a number of structural and functional abnormalities have been observed in dystrophic muscles, the primary inherited metabolic defect is not known. Recently, Thomson & Smith (1976 , 1978 have argued that the abnormalities in dystrophic muscles can be explained on the basis of reduced availability of adenine nucleotides, particularly adenosine triphosphate (ATP concentrations of purine nucleotides, by measuring the activity of hypoxanthine-guanine phosphoribosyltransferase (HGPRT; EC 2.4.2.8), the salvage-pathway enzyme which converts hypoxanthine, guanine and xanthine into their respective nucleotides, in blood and skeletal muscles of normal and dystrophic 129 ReJ and C57 BL/6J mice.
Materials and methods
Normal and dystrophic mice used in the present study were of the 129 ReJ and C57BL/6J strains reared locally from breeding pairs originally obtained from the Jackson Memorial Laboratory, Bar Harbor, Maine, U.S.A. Both sexes were used and all animals were 8-10 weeks of age. The animals were lightly anaesthetized with ether and exsanguinated by cutting the subclavian artery and vein. Blood was collected into heparinized tubes and these were kept on ice. Quadriceps muscles from both legs were quickly ,removed and placed in ice-cold distilled water. All subsequent procedures were carried out at 0"-4OC. The muscles were freed of visible connective tissue and fat, minced finely with scissors and homogenized (lo%, w/v) with a Polytron (Kinematica GMBH, Lucerne, Switzerland) for 20 s at a rheostat setting of 3. During homogenization the tube containing the muscle mince was kept in ice. The homogenate was centrifuged at 700 g for 10 min and the supernatant was kept on ice. Blood samples were also centrifuged at 700 g for 10 min at 4OC, and the plasma and buffy coat were discarded. The erythrocytes were washed three times with ice-cold phosphate-buffered sodium chloride solution (154 mmol/l) and subsequently haemolysed by diluting with ice-cold distilled water (1 : lo). Both the muscle extracts and haemolysates were dialysed overnight against Tris/HCI buffer (1.0 mmol/l), pH 8.0.
HGPRT activity was assayed by the method of Craft, Dean, Watts & Westwick (1970) . The incubation mixture consisted of 5-phosphorylribose 1-pyrophosphate (1.0 mmol/l) (dimagnesium salt; P-L Biochemicals Inc.) in Tris/HCl buffer (0.2 mmol/l), pH 8.0/MgC12 (6.0 mmol/l), 0.6 mmol of [8-l4C1hypoxanthine (specific radioactivity 16.8 mCi/mmol; The Radiochemical Centre, Amersham, Bucks, U.K.) and 50 pl of muscle extract or haemolysate, in a total volume of 200 p l . Thymidine triphosphate (3.3 mmol/l) was added to the muscle homogenate assays to inhibit 5'-nucleotidase (EC 3.1.3.5) activity (Gutensohn & Guroff, 1972) . The mixture was incubated at 37OC for 5 min and the reaction was stopped by adding 10 pl of EDTA (0.5 mol/l) and chilling in ice. In blanks, distilled water was substituted for the muscle extract or erythrocyte haemolysate.
The [8-14Clinosine monophosphate (IMP) formed was separated from the substrate by coelectrophoresis of 50 pl of the incubation mixture with 5.0 pl of unlabelled IMP (5.0 mg/ml) on Whatman 3MM paper at 7 k V (160 V/cm) for 25 min in sodium lactate buffer (20 mmol/l), pH 3.6, in a Miles Hivolt Ltd electrophoresis unit. The nucleotide-containing area on the paper was located by U.V. light (254 nm), cut out and the radioactivity was measured by liquid-scintillation counting in 0.5% (w/v) 2,5-bis-(5'-t-butylbenzoxazol-2'-yl)thiophene in toluene in a Nuclear-Chicago mark 1 scintillation spectrometer.
Protein was determined by the method of Lowry, Rosebrough, Farr & Randall (1951) with bovine serum albumin used as standards.
Results
HGPRT activity in blood and skeletal muscles of individual normal and dystrophic 129 ReJ and C57 BL/6J mice is shown in Fig. 1 . Enzyme activity is expressed as nmol h-' mg-1 of protein. Values are given as mean results 5 SEM, with number of animals in parentheses. Significance of difference was assessed by unpaired t-tests. HGPRT activity was 2.322 k 0.246 (10) and 2.301 k 0.277 (7) in blood of normal and dystrophic C57 BL/6J mice respectively. In 129 ReJ mice enzyme activity was higher L3.447 k 0.717 (7)1 in blood of dystrophic than of normal mice L1.928 k 0.175 (8)l (P < 0.05). Moreover, in this strain of mice, enzyme activity was elevated in blood of more severely affected mice, but was within normal range in blood of mice appearing to be healthy and dragging their hind limbs only when under stress (Fig. 1) .
In both strains of mice HGPRT activity was significantly higher in dystrophic than in normal skeletal muscle homogenate (P < 0.001). In 129 ReJ mice enzyme activity was 12.743 f 1-901 (8) in normal and 31.987 k 3.406 (6) in dystrophic muscle homogenate. In C57 BL/6J mice enzyme activity was 9-158 ? 1.536 (6) and 50.110 f 2.968 (7) in normal and dystrophic muscle homogenate respectively. In contrast to enzyme activity in blood, there were no differences in HGPRT activity in muscle homogenates of relatively healthy and severely affected dystrophic mice. Strain differences were not observed in HGPRT activity in blood or muscles of normal mice. However, enzyme activity was significantly higher in normal (P < 0.001 for both 129 ReJ and C57 BL/6J mice) or dystrophic (P < 0.001 for both 129 ReJ and C57 BL/6J mice) muscle than in the blood of the two strains of mice.
Discussion
Since increased HGPRT activity was observed only in erythrocyte haemolysates of severely affected dystrophic 129 ReJ mice, it seems likely that the erythrocyte abnormality is secondary to the dystrophic process. Nevertheless, because of the importance of the salvage pathway in the reutilization of purine bases for nucleotide synthesis, such changes in HGPRT activity could alter ATP concentrations of erythrocytes and affect the efficiency of the membrane-bound cation pumps (MirEevova, 1974; Wilkinson & Robinson, 1974) . Scanning electron-microscopic studies have shown :e muscular dystrophy 575 alterations in erythrocyte membranes of dystrophic mice (Morse & Howland, 1973) . In contrast to the enzyme activity in erythrocyte haemolysates, HGPRT activity in dystrophic muscle homogenates was two-to five-fold higher than in normal muscle. Such elevated HGPRT activity would suppress the pathway for new nucleotide synthesis by reducing the availability of 5-phosphorylribose 1-pyrophosphate. At the same time increased production of adenosine monophosphate (AMP) and guanosine monophosphate could occur. Indeed quantitative differences between acid-soluble nucleotides have been reported in dystrophic mouse muscle (Zymaris, Epstein, Saifer, Aronson & Volk, 1959) . AMP, cytosine, guanosine and uridine di-and tri-phosphate concentrations are higher in dystrophic than in normal muscles whereas ATP is decreased.
These changes in purine ribonucleotides are compatible with the observation that in murine dystrophic muscle, dehydrogenases requiring nicotinamide-adenine dinucleotide phosphate (NADP) were markedly elevated as compared with those requiring nicotinamide-adenine dinucleotide (NAD) (McCaman, 1960) . Such a shift in the dehydrogenases would favour energy metabolism in dystrophic muscle via the pentose monophosphate shunt. In the presence of ATP and ribose phosphate pyrophosphokinase (EC 2.7.6.1) the ribose 5-phosphate formed in the pentose pathway is converted into 5-phosphorylribose 1-pyrophosphate, which in turn would enhance HGPRT activity and favour the salvage pathway of nucleotide synthesis.
